Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects

Planta Medica

Volumn 76, Issue 7, 2010, Pages 671-677

  El Gendy, Mohamed A M ^a   Somayaji, Vishwa ^a   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aryl hydrocarbon receptor; Cytochrome P450 1a1; Harmaline; Harmine; Peganum harmala L.; Zygophyllaceae

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALKALOID DERIVATIVE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; HARMALINE; HARMAN; HARMINE; LUCIFERASE; MESSENGER RNA; METHANOL; PEGANUM HARMALA EXTRACT; PLANT EXTRACT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CATALYSIS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME INHIBITION; FRUITING; GEL MOBILITY SHIFT ASSAY; HERB; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PEGANUM HARMALA; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; ZYGOPHYLLACEAE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG SCREENING; ENZYME ACTIVATION; METABOLISM; PEGANUM; TUMOR CELL LINE;

PEGANUM HARMALA; ZYGOPHYLLACEAE;

ANIMALS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DRUG EVALUATION, PRECLINICAL; ENZYME ACTIVATION; MICE; PEGANUM; PLANT EXTRACTS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 77952081962     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240633     Document Type: Article

References (31)

1. Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, Sasco A J. The multitude and diversity of environmental carcinogens. Environ Res 2007 105 414-429
2. Mandal P K. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol [B] 2005 175 221-230
3. Puga A, Ma C, Marlowe J L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009 77 713-722
4. Dertinger S D., Nazarenko D A., Silverstone A E., Gasiewicz T A. Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 2001 22 171-177
5. Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 2004 95 1-6 (Pubitemid 38208399)
6. Nebert D W., Dalton T P., Okey A B., Gonzalez F J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004 279 23847-23850
7. Shah P P., Saurabh K, Pant M C., Mathur N, Parmar D. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutat Res 2009 670 74-78
8. Slattery M L., Samowtiz W, Ma K, Murtaugh M, Sweeney C, Levin T R., Neuhausen S. Cyp1a1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 2004 160 842-852
9. Hu Z, Yang X, Ho P C., Chan S Y., Heng P W., Chan E, Duan W, Koh H L., Zhou S. Herb-drug interactions: a literature review. Drugs 2005 65 1239-1282
10. Wiseman L R., Spencer C M. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers. Drugs Aging 1998 12 305-334
11. Wang H K. Plant-derived anticancer agents currently in clinical use or in clinical trials. I Drugs 1998 1 92-102
12. Whitlock J A., Krailo M, Reid J M., Ruben S L., Ames M M., Owen W, Reaman G. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol 2005 23 9179-9186
13. Amakura Y, Tsutsumi T, Nakamura M, Kitagawa H, Fujino J, Sasaki K, Yoshida T, Toyoda M. Preliminary screening of the inhibitory effect of food extracts on activation of the aryl hydrocarbon receptor induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biol Pharm Bull 2002 25 272-274
14. Lamchouri F, Settaf A, Cherrah Y, Zemzami M, Lyoussi B, Zaid A, Atif N, Hassar M. Antitumour principles from Peganum harmala seeds. Therapie 1999 54 753-758
15. Bellakhdar J. La pharmacopee marocaine traditionnelle. Medecine arabe ancienne et savoirs populaires. Paris Ibis Press 1997 529-530
16. Tahraoui A, El-Hilaly J, Israili Z H., Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J Ethnopharmacol 2007 110 105-117
17. Monsef H R., Ghobadi A, Iranshahi M, Abdollahi M. Antinociceptive effects of P eganum harmala L. alkaloid extract on mouse formalin test. J Pharm Pharm Sci 2004 7 65-69
18. Berrougui H, Isabelle M, Cloutier M, Hmamouchi M, Khalil A. Protective effects of Peganum harmala L. extract, harmine and harmaline against human low-density lipoprotein oxidation. J Pharm Pharmacol 2006 58 967-974
19. El Gendy M A., El-Kadi A O. Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. Drug Metab Lett 2009 in press[nl]
20. Anwar-Mohamed A, El-Kadi A O. Down-regulation of the carcinogen- metabolizing enzyme cytochrome P450 1a1 by vanadium. Drug Metab Dispos 2008 36 1819-1827
21. Korashy H M., El-Kadi A O. Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals. Toxicol Sci 2005 88 39-51
22. Lorenzen A, Kennedy S W. A fluorescence-based protein assay for use with a microplate reader. Anal Biochem 1993 214 346-348
23. Elbekai R H., El-Kadi A O. Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. Toxicol Lett 2007 172 106-119
24. Wong B Y., Lau B H., Yamasaki T, Teel R W. Modulation of cytochrome P-450IA1-mediated mutagenicity, DNA binding and metabolism of benzo[a]pyrene by Chinese medicinal herbs. Cancer Lett 1993 68 75-82
25. Chun Y J., Kim M Y., Guengerich F P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 1999 262 20-24
26. Lee J E., Safe S. Involvement of a post-transcriptional mechanism in the inhibition of Cyp1a1 expression by resveratrol in breast cancer cells. Biochem Pharmacol 2001 62 1113-1124
27. Sobhani A M., Ebrahimi S A., Mahmoudian M. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. J Pharm Pharm Sci 2002 5 19-23
28. Li Y, Liang F, Jiang W, Yu F, Cao R, Ma Q, Dai X, Jiang J, Wang Y, Si S. DH334, a beta-carboline anti-cancer drug, inhibits the CDK activity of budding yeast. Cancer Biol Ther 2007 6 1193-1199
29. Pulpati H, Biradar Y S., Rajani M. High-performance thin-layer chromatography densitometric method for the quantification of harmine, harmaline, vasicine, and vasicinone in Peganum harmala. J AOAC Int 2008 91 1179-1185
30. al-Allaf T A., Khuzaie R F., Rashan L J., Halaseh W F. Cytotoxic activity against a series of tumour cell lines of dimethyltin dichloride complexes with various donor ligands. Boll Chim Farm 1999 138 267-271
31. Yu A M., Idle J R., Krausz K W., Kupfer A, Gonzalez F J. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther 2003 305 315-322